More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.72B
EPS
3.35
P/E ratio
15.2
Price to sales
2.22
Dividend yield
--
Beta
0.670012
Previous close
$59.12
Today's open
$58.58
Day's range
$57.80 - $59.49
52 week range
$38.91 - $147.03
show more
CEO
Timothy P. Herbert
Employees
1333
Headquarters
Golden Valley, MN
Exchange
New York Stock Exchange
Shares outstanding
28966119
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare Conference
MINNEAPOLIS, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Piper Sandler 38th Annual Healthcare Conference on Tuesday, December 1, 2026.
GlobeNewsWire • 19 hours ago

Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Inspire Medical's strong Inspire V adoption, improving reimbursement clarity and patient access initiatives support growth despite near-term headwinds.
Zacks Investment Research • Nov 11, 2026

INSP Is Up 12.1% in Three Months: Can Its Rally Continue From Here?
Inspire Medical shares have rallied 12.1% in three months, but reimbursement hurdles and weak revenues raise questions about whether the gains can continue.
Zacks Investment Research • Nov 10, 2026

Inspire Medical Systems: The Moat Just Passed Its Worst-Case Stress Test
Inspire Medical Systems remains fundamentally strong despite severe reimbursement and coding disruptions, which the market has mispriced as permanent impairment. INSP's gross margin expanded to 86%, and operating cash flow reached $82.5M over nine months, even as revenue declined 7.9% year-over-year due to administrative headwinds. Management attributes nearly all revenue shortfall to coding issues, with growth expected to resume post-2027 as a permanent CPT code takes effect in January 2028.
Seeking Alpha • Nov 4, 2026

These Analysts Increase Their Forecasts On Inspire Medical After Strong Q3 Results
Inspire Medical Systems, Inc. (NYSE:INSP) reported upbeat earnings for the third quarter on Monday.
Benzinga • Nov 3, 2026

Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference
MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Stifel 2026 Healthcare Conference on Tuesday, November 10, 2026. Inspire is scheduled to present at 2:40 p.m.
GlobeNewsWire • Nov 3, 2026

Inspire Medical Systems Q3 Earnings Call Highlights
Inspire Medical Systems NYSE: INSP reported third-quarter revenue of $206.7 million, down 7.9% from a year earlier but up 3% sequentially, as stronger-than-expected U.S. performance offset weaker international results. The company said coding and reimbursement challenges continued to weigh on results, though management expressed growing confidence that the disruption is easing.
MarketBeat • Nov 3, 2026

Inspire Medical Systems, Inc. (INSP) Q3 2026 Earnings Call Transcript
Inspire Medical Systems, Inc. ( INSP ) Q3 2026 Earnings Call November 2, 2026 5:00 PM EST Company Participants Timothy Herbert - Founder, Chairman, CEO & President Matthew Osberg - Executive VP & CFO Conference Call Participants Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Adam Maeder - Piper Sandler & Co., Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Anthony Petrone - Mizuho Securities USA LLC, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Richard Newitter - Truist Securities, Inc., Research Division Travis Steed - BofA Securities, Research Division Keith Hinton - Prime Executions, Inc., Research Division Suraj Kalia - Oppenheimer & Co. Inc., Research Division Michael Sarcone - Jefferies LLC, Research Division David Rescott - Robert W. Baird & Co. Incorporated, Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Michael Kratky - Leerink Partners LLC, Research Division Daniel Markowitz - Evercore ISI Institutional Equities, Research Division Christopher Pasquale Presentation Operator Good afternoon.
Seeking Alpha • Nov 3, 2026

Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results
MINNEAPOLIS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2026.
GlobeNewsWire • Nov 2, 2026

Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings
The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • Nov 3, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Inspire Medical Systems Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.